As a result of the rapid spread of COVID-19 in 2020, countries across the world, including Canada, implemented various public health measures to curb COVID-19 transmission among the population such as minimizing contact between people with and people without COVID-19. These restrictions have greatly disrupted various healthcare services such as Hepatitis C Virus (HCV) prevention, testing, treatment and post-treatment follow-up. Limited information is available in Canada to understand the barriers and facilitators to HCV care during the COVID-19 pandemic, nor the impact of this disruption on progress towards achieving the World Health Organization’s goals of eliminating of HCV by 2030.
Health Care Providers (HCP) Focus Group Discussion
To understand the barriers and facilitators that health care providers had experienced while delivering HCV-related health care services during the COVID-19 pandemic, we are conducting a focus group with health care providers who had and are delivering HCV-related health care and support services during the pandemic. You will receive $50 as compensation for your time and participation. As a health care provider delivering HCV-related health care and support services during the pandemic, you are invited to participate in the focus group by e-mailing us at Analytics.PH@ubc.ca.
Health Care Providers (HCP) Survey
To understand the barriers and facilitators that health care providers had experienced while delivering HCV-related health care services during the COVID-19 pandemic, we have co-designed a survey with health care provider groups.
People who have Lived or are Living with HCV (PLLHCV) Survey
To understand how access to HCV-related medical and support services has been for PLLHCV, we have co-designed a survey with community groups serving PLLHCV.
Protecting your privacy
Safeguards are in place to ensure your privacy. Data collected in the surveys above follows strict privacy practices under the B.C. Freedom of Information and Protection of Privacy Act. The act governs how your information is collected, who sees it and how it is used.
We are grateful to the Canadian Network on Hepatitis C (CanHepC)/Canadian Institutes for Health Research (CIHR) for its financial support of this project.
Questions or inquiries
If you have any questions about this study, please e-mail Georgine Cua at Analytics.PH@ubc.ca
Principal Investigator: Dr. Naveed Janjua